Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

DDS > UNIT 1 > Flashcards

UNIT 1 Flashcards

1
Q

defined as an agent intended for use in the
diagnosis, mitigation, treatment, cure, or prevention of disease in humans or in other animals

A

DRUG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

may be derived from plant or animal sources, as
by-products of microbial growth, or through chemical synthesis, molecular modification, or biotechnology

A

New Drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

only difference between a drug and a
poison is the _____

A

Dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

art, practice, or profession of preparing, preserving, compounding, and dispensing medical drugs (according to merriam-webster)

A

Pharmacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

a facility that is licensed to dispense prescription medications and provide pharmaceutical care to patients

A

Pharmacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

responsible for ensuring the safe and effective use of medications

A

Pharmacies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

defined as the physical form in which a
medication is produced and dispensed. This includes
various forms such as tablets, capsules, liquids, creams, ointments, and injections.
the study of this includes physical, physiochemical, and clinical discussions

A

Dosage Form

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

defined by the US FDA (Food and Drug Administration), are instruments, machines, implants, or other similar articles that are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease. They can also be used to affect the structure or any function of the body.

A

Medical Devices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the Steps for Drug Development and Approval Process

A
  1. Discovery and Development
  2. Preclinical Research
  3. Investigational New Drug (IND) Application
  4. Clinical Trials
  5. New Drug Application (NDA)
  6. FDA Review and Approval
  7. Post-Market Surveillance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drug Development and Approval Process

__________: Understanding the biological basis of a disease and identifying potential drug targets.
- is a key step in drug discovery,
where a biological target is identified that a drug can bind to and cause a physiological change. The target can be a protein, nucleic acid, RNA, or gene.

A

Discovery and Development
Target Identification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Drug Development and Approval Process

_________: Designing and testing compounds for activity against the target.
•_________: Selecting promising compounds for further development.
- a chemical compound that shows promise as a treatment for a disease and may lead to the development of a new drug.

A

Discovery and Development
Drug Design and Screening
Lead Compound Identification

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Drug Development and Approval Process

Vitro and Vivo Studies

A

Preclinical Research

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

________: Laboratory tests to assess biological activity.

A

In Vitro Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

__________: Animal testing to evaluate safety, efficacy, and pharmacokinetics

A

In Vivo Studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how the drug is absorbed, distributed, metabolized, and excreted

A

pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Drug Development and Approval Process

• Submission to the FDA including preclinical data, proposed clinical trial plans, and manufacturing information.
• FDA review to ensure safety for human testing.

A

Investigational New Drug (IND) Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Drug Development and Approval Process

Phase 1 - Phase 4

A

Clinical Trials

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Clinical Trials

Small group of healthy volunteers (20-100) to assess safety, dosage, and side effects.

A

Phase I

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Clinical Trials

Larger group of patients (100-300) to evaluate efficacy and side effects

A

Phase II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Clinical Trials

Large-scale testing (1,000-3,000 patients) to confirm efficacy, monitor side effects, and compare with commonly used treatments.

A

Phase III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Takes place AFTER the FDA has approved the treatment, and involves thousands of participants over many years. This phase aims to gather
more information about the treatment’s long-term safety and effectiveness, as well as any other benefits or side effects.

A

Phase 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Drug Development and Approval Process

• Comprehensive submission to the FDA including all data from preclinical and clinical studies, proposed labeling, and manufacturing process
• FDA review to assess the drug’s safety, efficacy, and manufacturing

A

New Drug Application

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Drug Discovery and Development Process

________: A team of physicians, statisticians, chemists, pharmacologists, and other experts reviews the NDA

_________: An external panel may be convened to provide recommendations.

___________: The FDA approves the drugs if it determines that the benefits outweighs the risks

A

FDA Review and Approval Process
Review Team
Advisory Committee
Decision

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Drug Development and Approval Process

________: Post-approval studies to gather additional information on long-term effectiveness and safety.
•_______: Monitoring of adverse effects through the FDA’s MedWatch program

A

Post-Market Surveillance
Phase IV Trials
Adverse Event Reporting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Fill in the blanks:
Number of patients: Length:
Phase I ________ Several months

Purpose: Mainly safety

A

20-100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Fill in the blanks:
Number of patients: Length:
Phase II ________ Several months to 2 years

Purpose: some short-term safety but mainly effectiveness

A

100 to 300 (up to several hundreds)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Fill in the blanks:
Number of patients: Length:
Phase III ________ 1-4 years

Purpose: Safety, Effectiveness, dosage

A

1,000-3,000 (Several hundreds to several thousands)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Sources of New Drugs

A
  1. Natural Products
  2. Biotechnology and Genetic Engineering
  3. Peptides and Proteins
  4. Small Molecule Drugs
  5. Nanotechnology
  6. Regenerative Medicine
  7. Microbiome-Based Therapies
  8. RNA-Based Therapies
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Sources of New Drugs:

______: Marine environments are a rich source of novel compounds. For example, Trabectedin (Yondelis) is derived from the sea squirt Ecteinascidia turbinata and is used
in cancer treatment.

•______: Many drugs are derived from plants. For instance, Artemisinin from the sweet wormwood plant (Artemisia annua) is used to treat malaria.

•_______: Antibiotics like Penicillin, derived from the mold Penicillium notatum, and Streptomycin, from the bacterium Streptomyces griseus, are classic examples.

A

Natural Products
Marine Organisms
Plants
Microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Sources of New Drugs

•________: These are engineered to target specific cells. An example is Adalimumab (Humira), used to treat autoimmune diseases like rheumatoid arthritis.

•________: This involves modifying or manipulating genes to treat diseases. For example, Luxturna is a gene therapy for a specific
type of inherited vision loss.

•________: Human insulin (e.g., Humulin) produced by recombinant DNA technology is a well-known example.

A

Biotechnology and Genetic Engineering
Monoclonal Antibodies
Gene Therapy
Recombinant Proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Sources of New Drugs

•__________: Peptides are increasingly being developed for therapeutic use. Exenatide (Byetta), derived from the saliva of the Gila monster, is used to treat type 2 diabetes.

•__________: Enzymes and other proteins are being used as drugs, such as Dornase alfa (Pulmozyme), used in cystic fibrosis treatment to break down mucus.

A

Peptides and Proteins
Peptide-Based Drugs
Protein Therapeutics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Sources of New Drugs

• ___________: Advances in _________ allow for the creation of new small molecule drugs. For example, Sofosbuvir (Sovaldi) is a synthetic antiviral drug used to treat hepatitis C.

A

Small Molecule Drugs
Synthetic Chemistry

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Sources of New Drugs

_________: These can be used for targeted drug delivery. Doxil is a liposomal formulation of doxorubicin used in cancer treatment, designed to reduce toxicity and improve efficacy.

•________: Structures like micelles and dendrimers are being explored to improve drug solubility and delivery.

A

Nanotechnology
Nanoparticles
Nanocarriers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Sources of New Drugs

______: These are being investigated for their potential to regenerate damaged tissues. Prochymal, an adult stem cell therapy, is used for treating graft-versus-host disease

•______: Combining cells, scaffolds, and biologically active molecules to repair or replace damaged tissues, such as in the development of bioengineered skin

A

Regenerative Medicine
Stem Cells
Tissue Engineering

35
Q

Sources of New Drugs

__________: These are used to modulate the gut microbiome for therapeutic purposes. Fecal microbiota transplantation (FMT) is used to treat recurrent Clostridium difficile infections

•__________: Viruses that target bacteria, known as bacteriophages, are being explored as alternatives to antibiotics. For example, phase therapy is being investigated for treating antibiotic-resistant infections

A

Microbiome-Based Therapies
Probiotics and Prebiotics
Bacteriophages

36
Q

Sources of New Drugs:

•____________: This technology can silence specific genes involved in disease. Patisiran (Onpattro) is an RNAi therapeutic for hereditary transthyretin-mediated amyloidosis.

•_____________: The COVID-19 vaccines developed by Pfizer-BioNTech and Moderna use mRNA technology to elicit an immune response against the
virus

A

RNA-Based Therapies
RNA Interference (RNAi)
mRNA Vaccines

37
Q

Methods of Drug Discovery

A

Traditional Methods
Modern Methods
Biotechnology-Based Methods
Phenotypic Screening
Network Pharmacology

38
Q

Traditional Methods

A

Natural Product Screening
Serendipity

39
Q

Methods of Drug Discovery
Traditional Methods

• Description: Involves extracting and testing compounds from natural sources such as plants, microorganisms, and marine organisms.
• Advantages: Rich source of bioactive compounds, many drugs have
been successfully derived this way (e.g., penicillin, paclitaxel).
• Limitations: Time-consuming, complex extraction and purification
processes, variability in natural sources.

A

Natural Products Screening

40
Q

Methods of Drug Discovery
Traditional Methods

Description: Involves the unexpected discovery of drugs, often while researching something else.
• Advantages: Can lead to breakthrough medications (e.g.,penicillin, sildenafil).
• Limitations: Unpredictable, relies heavily on chance and observation.

A

Serendipity (Accidental Discovery)

41
Q

Methods of Drug Discovery
Modern Methods

A

High-Throughput Screening (HTS)
Structure-Based Drug Design (SBDD)
Ligand-Based Drug Design (LBDD)
Computational Drug Discovery

42
Q

Methods of Drug Discovery
Modern Methods

• Description: Uses automated equipment to rapidly test thousands of compounds for biological activity against a target.

• Advantages: Efficient, can screen large libraries of compounds quickly, high potential for discovering novel drug candidates.

• Limitations: Requires substantial investment in technology and infrastructure, high rate of false positives/negatives

A

High-Throughput Screening (HTS)

43
Q

Methods of Drug Discovery
Modern Methods

• Description: Involves designing drugs based on the 3D structure of the target protein, often determined by X-ray crystallography or NMR spectroscopy.

• Advantages: Rational design process, can optimize binding affinity and specificity, reduces trial and error.

• Limitations: Requires detailed structural information, not all targets have known structures

A

Structure-Based Drug Design (SBDD)

44
Q

Methods of Drug Discovery
Modern Methods

•Description: Uses knowledge of molecules that bind to the target to design new compounds. Often employs computational methods to identify key features.

•Advantages: Useful when the target structure is unknown, leverages existing ligand information.

•Limitations: Dependent on the quality and quantity of known ligands, can be less precise than SBDD

A

Ligand-Based Drug Design (LBDD)

45
Q

Methods of Drug Discovery
Modern Methods

•Description: Utilizes computer algorithms and models to predict the interaction between drugs and targets, often through virtual screening.

•Advantages: Cost-effective, can screen vast compound libraries, speeds up the initial phases of drug discovery.

•Limitations: Models may not accurately predict real-world interactions, dependent on the quality of input data.

A

Computational Drug Discovery

46
Q

Methods of Drug Discovery
Biotechnology-Based Methods

A

Monoclonal Antibody Technology
Gene Therapy and RNA-Based Approaches

47
Q

Methods of Drug Discovery
Biotechnology-Based Methods

• Description: Involves creating antibodies that specifically target antigens on diseased cells.

• Advantages: High specificity, can target previously “undruggable” targets, successful in treating cancers and autoimmune diseases.

• Limitations: Expensive production process, potential for immunogenicity.

A

Monoclonal Antibody Technology

48
Q

Methods of Drug Discovery
Biotechnology-Based Methods

• Description: Involves modifying genetic material to treat diseases. Includes techniques like RNA interference (RNAi) and CRISPR gene editing.

• Advantages: Can target genetic causes of disease, potential for long-lasting effects, highly specific.

• Limitations: Delivery challenges, potential off-target effects, ethical and regulatory concerns.

A

Gene Therapy and RNA-Based Approaches

49
Q

Methods of Drug Discovery

• Description: Involves screening compounds based on their observable effects on cells, tissues, or whole organisms, without prior knowledge of the specific target.

• Advantages: Can discover drugs with novel mechanisms of action, useful for complex diseases.

• Limitations: Identifying the exact mechanism can be challenging, may require extensive follow-up studies.

A

Phenotypic Screening

50
Q

Methods of Drug Discovery

• Description: Examines the complex interactions between drugs and multiple targets within biological networks.

• Advantages: Can provide insights into multi-target drugs, helps in understanding polypharmacology, useful for complex diseases.

• Limitations: Computationally intensive, requires comprehensive biological network data.

A

Network Pharmacology

51
Q

Organizational Structure Required for cGMP

A

Quality Control Unit (QCU)
Production Department
Engineering and Maintenance
Research and Development (R&D)
Regulatory Affairs

52
Q

This is a critical component within any pharmaceutical manufacturing organization.
____ is responsible for the oversight and enforcement of cGMP regulations, ensuring that all
procedures are followed and that products meet quality standards.

A

Quality Control Unit (QCU)

53
Q

Responsible for the actual manufacturing
processes, including formulation, processing, packaging, and labeling.

A

Production Department

54
Q

Ensures that all manufacturing equipment
and facilities are properly maintained and function correctly.

A

Engineering and Maintenance

55
Q

Conducts studies to develop new products and improve existing ones, ensuring that they comply with cGMP standards.

A

Research and Development (R&D)

56
Q

Ensures that the company complies with all regulatory requirements and handles submissions to the FDA and other regulatory bodies.

A

Regulatory Affairs

57
Q

• Standardization: Written cGMP guidelines ensure that manufacturing processes are standardized. This consistency helps in producing pharmaceutical products that meet predetermined quality criteria every time.

• Reproducibility: Clear, documented procedures allow for reproducibility of processes, which is crucial in maintaining product quality across different batches.

A

Consistency in Manufacturing Processes

58
Q

•_________: Compliance with written cGMP guidelines is mandatory for regulatory approval. The FDA and other regulatory bodies require detailed documentation of manufacturing practices to ensure products are safe and effective.

•_________: Written cGMP records provide the necessary documentation for regulatory audits and inspections, demonstrating adherence to legal and regulatory standards.

A

Compliance with Regulatory Requirements
Regulatory Adherence
Audit and Inspection

59
Q

•___________: Documented procedures reduce the likelihood of errors by providing clear instructions for each step of the manufacturing process.

•___________: Written cGMP guidelines include protocols for handling deviations and non-conformances, ensuring that any issues are promptly addressed and rectified.

A

Quality Assurance and Control
Error Reduction
Deviation Management

60
Q

•_________: Written procedures serve as a training tool for new employees, ensuring they understand and follow the correct methods.

•_________: Clear documentation assigns responsibility and accountability to specific individuals or teams, promoting a culture of quality and responsibility.

A

Training and Accountability
Employee Training
Accountability

61
Q

________: Written cGMP guidelines help identify and mitigate risks associated with the manufacturing process, ensuring product safety.

•________: Consistent adherence to written procedures ensures that each product meets its intended quality standards providing effective and reliable medications to patients

A

Product Safety and Efficacy
Risk Management
Consistency in Quality

62
Q

•__________: Documented processes can be reviewed and analyzed for continuous improvement. This helps in refining manufacturing practices and enhancing product quality over time.

•__________: Written records allow for the collection and analysis of data, which can be used to make informed decisions about process improvements.

A

Continuous Improvement
Process Improvement
Feedback Loop

63
Q

•__________: Written cGMP guidelines provide a record of compliance with regulatory requirements, which can be crucial in legal matters or disputes.

•__________: Detailed records ensure that every step of the manufacturing process is traceable, which is essential for investigations in the event of product recalls or quality issues.

A

Legal Protection
Documentation of Compliance
Traceability

64
Q

Written cGMP guidelines provide a structured framework for ensuring the quality and safety of pharmaceutical products.

A
  1. Consistency in Manufacturing Processes
  2. Compliance with Regulatory Requirements
  3. Quality Assurance and Control
  4. Training and Accountability
  5. Product Safety and Efficacy
  6. Continuous Improvement
  7. Legal Protection
65
Q

Various Types of Tamper-Evident Packaging

A

Shrink Bands
Tamper-evident tape
Tamper-evident labels
Flexible pouches
Breakable caps and seals
Blister packs
Foil seals
Film wrapper
Bubble pack
Aerosol Container

66
Q

Sealed tubes, specifically _____, are tampered resistant, since it has sealed bottoms

A

Plastic tubes

67
Q

Made of PVC plastic, ______ can wrap around the neck, cap, or cover of a container. If the product is tampered with or damaged, the ______ will show that it has been compromised. Perforated _____can improve the user experience.

A

Shrink Bands

68
Q

A strip of material with a perforated edge that’s applied to the outside of a package. It can be easily torn off to reveal if the package has been opened. _______ is often used to secure large items like cartons, crates, snd boxes during shipping.

A

Tamper-evident tape

69
Q

These labels can tear or leave a residue if someone tries to open the package, indicating that the product may have been compromised. Hershey’s is one company that uses _____ on some of its packaging.

A

tamper-evident labels

70
Q

A popular choice in the food industry, _______can often be resealed so that users can continue to use the package until all the product has been consumed.

A

Flexible pouches

71
Q

These______ break or show visible evidence when opened

A

Breakable caps and seals

72
Q

encase individual doses in a plastic or foil material,
which must be punctured or peeled away to access the product.

A

Blister packs

73
Q

These seals are usually found under caps and provide a barrier that must be peeled or punctured to access the product.

A

Foil Seals

74
Q

Scale and Volume

Large-Scale Production:
Medications are produced in
large quantities to meet the
needs of a wide patient
population.

Batch Consistency: Ensures
uniformity and consistency
across all produced units within
a batch.

A

Pharmaceutical Manufacturing

75
Q

Scale and Volume

Small-Scale Production:
Medications are prepared in
small quantities, often on a per-
patient basis.
Customization: Tailored to the
specific needs of an individual
patient, often when
commercially available drugs are
unsuitable.

A

Extemporaneous Compounding

76
Q

Regulatory Oversight:

Regulated by Agencies: Subject
to strict regulations and
oversight by agencies such as
the FDA (Food and Drug
Administration) in the U.S. and
EMA (European Medicines
Agency) in Europe.

cGMP Compliance: Must
comply with current Good
Manufacturing Practices
(cGMP) to ensure quality,
safety, and efficacy.

A

Pharmaceutical Manufacturing

77
Q

Regulatory Oversight

Less Stringent Regulation:
While still regulated,
compounding pharmacies have
different and often less
stringent oversight compared to
manufacturing facilities.

USP <795> and <797>: Must
comply with standards set by
the United States
Pharmacopeia (USP) for non-
sterile and sterile
compounding, respectively.

A

Extemporaneous Compounding

78
Q

Product Formulations

Standardized Formulations:
Medications are produced with
standardized dosages and
formulations to ensure
consistency.

A

Pharmaceutical Manufacturing

79
Q

Product Formulations:

Customized Formulations:
Dosages and formulations can
be customized based on patient-
specific needs, such as allergies,
age, or specific medical
conditions.

A

Extemporaneous Compounding

80
Q

Quality Control

testing and quality control
measures are implemented to
ensure each batch meets
predefined standards.

Documentation and
Traceability: Detailed
documentation for every step
of the manufacturing process
for traceability and
accountability

A

Pharmaceutical Manufacturing

81
Q

Quality Control

Pharmacist’s Expertise: Quality
relies heavily on the skill and
expertise of the compounding
pharmacist.
Limited Testing: Quality testing
is more limited compared to
large-scale manufacturing.

A

Extemporaneous Compounding

82
Q

Manual Processes/Automation and Technology

Automation and Technology:
Advanced Technology: Utilizes
advanced machinery and
technology for efficient
production.
Automation: Many processes
are automated to increase
efficiency and reduce human
error.

A

Pharmaceutical Manufacturing

83
Q

Manual Processes/Automation
and Technology:

Manual Processes
Manual Preparation:
Medications are often prepared
manually or with minimal
automation.
Individualized Care: Focuses on
providing personalized care
rather than mass production.

A

Extemporaneous Compounding

84
Q

•____________: This technology allows the rapid testing of thousands of synthetic compounds to identify potential drugs.

A

High-Throughput Screening

DDS (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions